The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Odrik 0.5mg Hard Capsules

0.5 milligram(s) Capsule, hard

Mylan IRE Healthcare LimitedPA2010/005/001

Main Information

Trade NameOdrik 0.5mg Hard Capsules
Active SubstancesTrandolapril
Strength0.5 milligram(s)
Dosage FormCapsule, hard
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/005/001

Group Information

ATC CodeC09AA ACE inhibitors, plain
C09AA10 trandolapril


Withdrawn Date04/08/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back